Explore more publications!

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on December 22, 2025

mEinstein Positions Privacy-by-Design as a Core Principle for Consumer AI Platforms
mEinstein Develops an On-Device AI System Designed to Adapt Across Life Stages
mEinstein Introduces a Consumer Platform Focused on User-Controlled Data Licensing
DIVINE WATER Launches Glass-Bottled Natural Spring Water for Health-Focused Consumers
Nicholas Clifford Launches Debut Fantasy Novel The Sea Dragon’s Vault, Reviving High-Stakes Seafaring Adventure
G2 Recognizes partnrUP as Best Influencer Marketing Platform for: Support & Easiest Admin in Winter Reports
Documentary ‘Third Degree Burnout – A Survivor’s Guide’ Receives United Nations International Impact Award
ZSuite Tech Appoints Brian Noyle as Chief Product and Technology Officer
BDMT GLOBAL CO-SPONSORS VIP PRIVATE INVESTOR EVENT DURING CES 2026 WITH ‘MASS’ SOLUTIONS FOR SELECT INNOVATORS
The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS
ConnectM Announces Proposed Reverse Stock Split to Support Planned Uplisting to a National Exchange
UniFirst Confirms Receipt of Unsolicited, Non-Binding Proposal from Cintas Corporation
UniFirst Corporation Plans to Announce First Quarter Results on January 7, 2026
Paytronix and Deliverect Partner to Enable Seamless Operations Across Online Orders for Restaurants
Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy
Peer to Peer Network, Inc. Announces Contract With Hopscotch Air® to Deploy Tier-1 AI Communications Suite
DemandScience Earns Top Rankings in G2 Winter 2026 Reports
Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease
Leading Quantum Scientists Join Zapata’s Scientific Advisory Board, Validating Its Software-First Approach
Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions